Solentim & ATUM announce technology collaboration
Integrating Solentim’s VIPS™ hardware for isolating single cells with ATUM’s efficient Leap-In Transposase® expression technology, enable rapid, high expression, stable cell line development
Solentim is a life sciences instruments company which enables customers to develop an increased number of new and better biopharmaceuticals by providing practical, innovative solutions to help with the challenges of drug discovery and development.
Commercial stable cell line development for biopharmaceutical production and gene therapy is a high value process which is inherently expensive and historically takes a significant amount of time. Solentim® has established itself over the past eight years as a significant leader and innovator of new products in the cell line development arena.
The Cell Metric® product range of bright field imaging stations has a large global installed base of customers, and is recognised as the leader for documenting proof of clonal origin for Master Cell Banks in IND filings to the medicines regulators.
Solentim’s second product range - an automated single cell cloning system called VIPS™ - combines single cell printing into microtiter plates with whole well imaging for clonality.
We help to optimise workflows
Providing solutions for customers working in cell line development in these areas…
Customers working with hybridomas and B cells to discover novel antibody sequences and produce diversity of antibodies. These groups may also be involved in the development of diagnostic antibodies
VIEW OUR WEBINAR
"How a Top-5 Pharma Doubled the Speed of Cell Line Development"
Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development
NEWS – Bournemouth, UK – 14th January 2019: Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement. This
NEWS – Bournemouth, UK – 10th January 2019: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce the appointment of Claire Richards as their new
NEWS - Bournemouth, UK – 3rd January 2019: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce they will be exhibiting at the Annual PepTalk
In this latest blog by Solentim’s Dr Ian Taylor, the advent of digital biology is discussed. This is compared and contrasted with smarter automation, transformative new biology and better control
Never far from scientific and mainstream news, CRISPR is regularly hailed as one of the most important scientific discoveries of our time. With potential applications across wide-ranging fields from medicine
Aaron Figg & Ian Taylor at the Deloitte UK Technology Fast 50 Solentim named as one of the top 50 fastest growing UK technologies companies of
Aaron Figg, Dave Elverd, Mr (Ian) Angus Campbell (Her Majesty’s Lord-Lieutenant of Dorset), Ian Taylor, Sky Jiang Solentim’s business excellence and expertise in cell line development
Damp weather did little to suppress the energy in the rooms at last week’s 10th Annual BioProcessing Summit in Boston. There were over 1,000 delegates, including many from the US
Patricia Fitzpatrick Diamond discusses recent technological advances aiding single cell cloning, including Solentim’s VIPS™, in GEN. To meet regulatory standards, recombinant proteins must be produced from a single cell line,
Customer data presentation at the Bioprocessing Summit in Boston NEWS - Bournemouth, UK – 30th July, 2018: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce that